Literature DB >> 8924517

Endothelial dysfunction in atherosclerosis.

R Busse1, I Fleming.   

Abstract

Endothelial injury or dysfunction has been proposed to be one of the initiating events of atherosclerosis and is associated with an apparent decrease in the production of the vasodilator autacoid nitric oxide (NO). The nature of the endothelial dysfunction resulting in an attenuation of NO-mediated responses is unknown although possibilities include decreased substrate availability, decreased expression of the NO synthase, imbalance between the production of endothelium-derived constricting and relaxing factors, production of an endogenous NO synthase inhibitor and overproduction of oxygen-derived free radicals. While experimental evidence has been provided to support almost all of these possibilities, increased production of superoxide anions within the vascular wall is currently favoured as an explanation for the observed changes in vascular responsiveness and the characteristic loss of the anti-adhesive properties of the endothelium in the early stages of atherosclerosis. The altered ratio of NO/superoxide anion (O2-) production has been proposed to alleviate intrinsic inhibition of the transcription factor NF kappa B and lead to enhanced expression of adhesion molecules and chemotactic factors at the endothelial surface. The aim of this short review is to summarise recent findings which suggest that an imbalance in the production of NO and O2- within the vascular wall is one of the earliest events to occur in the atherogenic process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8924517     DOI: 10.1159/000159147

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  29 in total

Review 1.  Vascular oxidant stress: molecular mechanisms and pathophysiological implications.

Authors:  G Zalba; J Beaumont; G San José; A Fortuño; M A Fortuño; J Díez
Journal:  J Physiol Biochem       Date:  2000-03       Impact factor: 4.158

2.  Growth-inhibitory effect of cyclic GMP- and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression.

Authors:  N Kronemann; W A Nockher; R Busse; V B Schini-Kerth
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 3.  The dynamic vasa vasorum.

Authors:  Erik L Ritman; Amir Lerman
Journal:  Cardiovasc Res       Date:  2007-06-29       Impact factor: 10.787

Review 4.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

5.  The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis.

Authors:  A Hacker; S Müller; W Meyer; G Kojda
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  Decreased production of neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis.

Authors:  L S A Capettini; S F Cortes; J F Silva; J I Alvarez-Leite; V S Lemos
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 7.  Putative mechanisms for vascular damage by homocysteine.

Authors:  M F Bellamy; I F McDowell
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

8.  Steroid-sensitive gene 1 is a novel cyclic GMP-dependent protein kinase I substrate in vascular smooth muscle cells.

Authors:  Guang-rong Wang; Howard K Surks; K Mary Tang; Yan Zhu; Michael E Mendelsohn; Robert M Blanton
Journal:  J Biol Chem       Date:  2013-07-06       Impact factor: 5.157

9.  Vascular relaxation induced by aqueous extract of Lespedeza cuneata via the NO-cGMP pathway.

Authors:  Jun Kyoung Lee; Dae Gill Kang; Ho-Sub Lee
Journal:  J Nat Med       Date:  2011-05-24       Impact factor: 2.343

10.  HIV-1 antiretrovirals induce oxidant injury and increase intima-media thickness in an atherogenic mouse model.

Authors:  Bo Jiang; Valeria Y Hebert; Alok R Khandelwal; Karen Y Stokes; Tammy R Dugas
Journal:  Toxicol Lett       Date:  2009-03-09       Impact factor: 4.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.